LC Method Development and Strategies

Characterization of Impurities and Degradants Using Mass Spectrometry

Volumn , Issue , 2011, Pages 59-79

  Xue, Gang ^a   Zhao, Yining ^a  

^a PFIZER INC   (United States)

Author keywords

Gradient and temperature optimization "tweaked" to fine tune resolution, reducing runtime; High efficiency separation, and UHPLC (ultra high performance liquid chromatography) instruments and very high efficiency separation within a short analysis time; LC method development and strategies, accurate assessment of impurity profiles of active pharmaceutical ingredients (APIs) in pharmaceutical analysis

Indexed keywords

EID: 84886057245     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470921371.ch2     Document Type: Chapter

References (26)

1. Ryan, T. W. (1998), Anal. Lett. 31, 2447.
2. Wiltshire, H.; Nedderman, A. (2008), in Venn, R. F., ed., Principles and Practice of Bioanalysis, 2nd ed., CRC Press, Boca Raton, FL, pp. 141-150.
3. Cowan, D. A. (2008), Essays in Biochemistry, Vol 44, Portland Press Ltd., pp. 139-148.
4. Maurer, H. H. (2008), Handbook of Analytical Separations, Vol. 6, Elsevier, B.V., pp. 425-445.
5. Thompson, R.; LoBrutto, R. (2007), HPLC Pharm. Sci. 641.
6. Bynum, K. C. (2007), Sep. Sci. Technol. 8, 297.
7. Smith, J.; Wikfors, R.; Fogelman, K.; Berger, T. A. (2004), Abstracts of Papers, 227th ACS Natl. Meeting, Anaheim, CA, March 28-April 1, 2004.
8. Berger, T. A.; Smith, J.; Fogelman, K.; Kruluts, K. (2002), Am. Lab. 34, 14.
9. Marsh, A.; Broderick, M.; Altria, K.; Power, J.; Donegan, S.; Clark, B. (2008), Meth. Molec. Biol. 384, 205.
10. Altria, K.; Marsh, A.; Sanger-van de Griend, C. (2006), Electrophoresis 27, 2263.
11. Altria, K. D.; Chen, A. B.; Clohs, L. (2001), LC-GC Eur. (Liquid Chromatography-Gas Chromatography Europe) 14, 736.
12. Snyder, L. R.; Carr, P. W.; Rutan, S. C. (1993), J. Chromatogr. A 656, 537.
13. Xue, G.; Bendick, A. D.; Chen, R.; Sekulic, S. S. (2004), J. Chromatogr. A 1050, 159.
14. Lestremau, F.; Cooper, A.; Szucs, R.; David, F.; Sandra, P. (2006), J. Chromatogr. A 1109, 191.
15. Demond,W.; Kenley, R. A.; Italien, J. L.; Lokensgard, D.;Weilersbacher, G.; Herman, K. (2000), AAPS (American Association of Pharmaceutical Scientists) PharmSciTech. 1, np.
16. Van Gyseghem, E.; Crosiers, I.; Gourvenec, S.; Massart, D. L.; Vander Heyden, Y. (2004), J. Chromatogr. A 1026, 117.
17. Van Gyseghem, E.; Jimidar, M.; Sneyers, R.; Redlich, D.; Verhoeven, E.; Massart, D. L.; Vander Heyden, Y. (2005), J. Chromatogr. A 1074, 117.
18. Wang, X.; Li, W.; Rasmussen, H. T. (2005), J. Chromatogr. A 1083, 58.
19. Pellett, J.; Lukulay, P.; Mao,Y.; Bowen,W.; Reed, R.; Ma, M.; Munger, R. C.; Dolan, J.W.; Wrisley, L.; Medwid, K.; Toltl, N. P.; Chan, C. C.; Skibic, M.; Biswas, K.; Wells, K. A.; Snyder, L. R.; (2006), J. Chromatogr. A 1101, 122.
20. Ferguson, P.; Whitlock, M. (2005), Pfizer Internal Report.
21. Massart, D. L.; Vander Heyden, Y. (2005), LC-GC Eur. 18, 84.
22. Euerby, M. R.; Petersson, P. (2006), The use of principal component analysis for the characterization of reversed-phase liquid chromatographic stationary phases, in Kromidas, S., ed., HPLC Made to Measure, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 264-279.
23. Liu, Z.; Patterson, D. G. Jr.; Lee, M. L. (1995), Anal. Chem. 67, 3840.
24. Bemish, R. (2007), Pfizer Internal Report.
25. Lestremau, F.; de Villiers, A.; Lynen, F.; Cooper, A.; Szucs, R.; Sandra, P. (2007), J. Chromatogr. A 1138, 120.
26. Snyers, R.; Janssens,W.; Huybrechts, T.; Vrielynck, S.; Somers, I. (2007), Conference oral presentation at HPLC 2007, Ghent, Belgium, June 17-21.